Back

Effect of empagliflozin on hydroelectrolytic balance in patients with heart failure with reduced ejection fraction

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Pharmacology and Pharmacotherapy Cardiovascular Pharmacotherapy, Other HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Susana Del Prado Diaz

Ramon and Cajal University Hospital, Madrid (Spain)

12 More presentations in this session

Presentation thumbnail
Doctor J. Fallon (Cleveland, US)
Abstract Slides
Presentation thumbnail
Mr C. Moliner-Abos (Barcelona, ES)
Abstract
Presentation thumbnail
Doctor J. De Almeida (Coimbra, PT)
Abstract
Presentation thumbnail
Professor M. Ledwidge (Dublin, IE)
Abstract
Presentation thumbnail
Assistant Professor G. Alonso Salinas (Pamplona, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Pharmacology and Pharmacotherapy

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Empagliflozin in a real-world chronic heart failure population
3 September 2019
thumbnail
Congress Session
Late-breaking science in acute heart failure
19 May 2025
thumbnail
Congress Presentation
Empagliflozin reduces extracellular volume and myocardial sodium content in patients with heart failure and preserved ejection fraction and correlates with reverse cardiac remodeling (EMPAG CMR-HF)
29 August 2025
thumbnail
Congress Presentation
Trace element equilibrium in acute heart failure and the effect of empagliflozin
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources